Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
214 participants
INTERVENTIONAL
2015-10-16
2024-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Material and Methods:
Population: healthy subjects, patients with brain injury Electroencephalographic study to research attentional modulation during different kind of stimulation (visual, auditory, tactile)
Sudy 1: passive recording.
Study 2: active recording (instruction of attentional control given to the subject).
Study 3: active recording with a feedback obtained after a processing of the brain activity.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Electrophysiological assessment of Healthy subjects
Experiences 1, 2 and 3 with healthy subjects
electrophysiological evaluation
electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1, 2, 3 : one session maximum by experience
Electrophysiological assessment of patients
Experiences 1, 2 and 3 with patients
electrophysiological evaluation of patients
electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 2 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 3 : Stimulation = auditory or visual ; possibility of several sessions if the patient is tired.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
electrophysiological evaluation
electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1, 2, 3 : one session maximum by experience
electrophysiological evaluation of patients
electrophysiological assessment (experience 1 : passive ; experience 2 : active versus passive ; experience 3 : active, with feedback) Experience 1 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 2 : maximum one session by sensory modality of stimulation (auditory, tactile, or visual) Experience 3 : Stimulation = auditory or visual ; possibility of several sessions if the patient is tired.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis :
* Locked-in syndrome :
\< Brainstem injury, without any evolution for at least 3 week, etiology : vascular, traumatic \< Amyotrophic Lateral Sclerosis \< Following damage to the central or peripheral nervous system
* Or Minimal conscious state or Unresponsive Wakefulness Syndrome consecutive to a severe acquired brain injury for at least one month
* Or with a severe brain injury, since birth or acquired, for at least one month
* Or with Guillain-Barré syndrome
* Subjects affiliated to social security;
* Signature of consent form by the patient or by a relative (family member or "the trusted person") if obtaining a consent is impossible
* Adults, man or woman, left or right-handed, from 18 years old to 80 years-old ;
* Without known auditory impairment
* Subjects able to understand the experimental instructions
* Subjects affiliated to social security;
* Signature of consent form
Exclusion Criteria
* For healthy subjects : history of brain injury
* Pregnant women or breastfeeding women
* Person under legal protection
* Medico-legal conflicts
* Absence of consent by the subject or the patient or his/her representant
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacques LUAUTE, MD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Médical de L'argentière
Aveize, , France
Centre Hospitalier Georges Claudinon
Le Chambon-Feugerolles, , France
Hospices Civils de Lyon
Lyon, , France
Centre de Recherche en Neurosciences de Lyon
Lyon, , France
CHU de Nantes
Nantes, , France
CHU de Nîmes
Nîmes, , France
APHP - Hôpital de la Pitié Salpêtrière
Paris, , France
APHP - Hôpital Raymond Poincaré
Paris, , France
Hôpital Nord CHU Saint Etienne
Saint-Etienne, , France
Hospices civils de Lyon, Hôpital Henry Gabrielle,
Saint-Genis-Laval, , France
Centre Médical Germaine Revel
Saint-Maurice-sur-Dargoire, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Seguin P, Maby E, Fouillen M, Otman A, Luaute J, Giraux P, Morlet D, Mattout J. The challenge of controlling an auditory BCI in the case of severe motor disability. J Neuroeng Rehabil. 2024 Jan 18;21(1):9. doi: 10.1186/s12984-023-01289-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A00635-44
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL15_0216
Identifier Type: -
Identifier Source: org_study_id